Diagnosis and management for acute ischemic stroke
نویسندگان
چکیده
منابع مشابه
dysphagia in acute ischemic stroke
Introduction: Swallowing dysfunction complicates acute strokes in 25-32% of cases and directly affects patientschr('39') prognosis and recovery. Dysphagia complicates the course of acute strokes through its potential of the development of chest infection, nutritional problems, and dehydration. Dysphagia is also an independent predictor of respiratory morbidity and mortality in acute stroke. In...
متن کاملManagement of acute ischemic stroke.
Stroke is the third leading cause of death and the leading cause of disability in the United States. This article summarizes the management of acute ischemic stroke, including conventional and novel therapies. The article provides an overview of the initial management, diagnostic work-up, treatment options, and supportive measures that need to be considered in the acute phase of ischemic stroke.
متن کاملAcute Stroke – Diagnosis and Management
Stroke (noun): a sudden disabling attack... caused by an interruption in the flow of blood to the brain, especially through thrombosis. Stroke is a considerable cause of mortality and morbidity in the UK. The field of stroke medicine has changed considerably in recent years with the development of hyper-acute treatments such as thrombolysis, specialist stroke units and a better understanding of...
متن کاملAcute ischemic stroke management: medical management.
The initial management of a patient with suspected stroke necessitates a rapid and focused evaluation. Establishing the time of symptom onset, performing a focused neurologic examination, and interpreting ancillary tests facilitates delivery of acute stroke therapies to eligible patients. This review emphasizes the fundamentals of urgent stroke evaluation and evidence-based acute ischemic strok...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rinsho Shinkeigaku
سال: 2008
ISSN: 0009-918X,1882-0654
DOI: 10.5692/clinicalneurol.48.866